Omalizumab Interactions
There are 32 drugs known to interact with omalizumab, along with 1 disease interaction. Of the total drug interactions, 3 are major, 20 are moderate, and 9 are minor.
- View all 32 medications that may interact with omalizumab
- View omalizumab disease interactions (1)
Most frequently checked interactions
View interaction reports for omalizumab and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Amitiza (lubiprostone)
- Augmentin (amoxicillin / clavulanate)
- CoQ10 (ubiquinone)
- EpiPen (epinephrine)
- Flonase (fluticasone nasal)
- Keflex (cephalexin)
- Metoprolol Succinate ER (metoprolol)
- Naproxen Sodium DS (naproxen)
- Paracetamol (acetaminophen)
- Paxlovid (nirmatrelvir / ritonavir)
- ProAir HFA (albuterol)
- Protonix (pantoprazole)
- Provigil (modafinil)
- Quercetin (bioflavonoids)
- Singulair (montelukast)
- Spiriva (tiotropium)
- Spiriva Respimat (tiotropium)
- Symbicort (budesonide / formoterol)
- Tylenol (acetaminophen)
- Ventolin (albuterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vyvanse (lisdexamfetamine)
- Zantac (ranitidine)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
Omalizumab disease interactions
There is 1 disease interaction with omalizumab which include:
Report options
QR code containing a link to this page
More about omalizumab
- omalizumab consumer information
- Compare alternatives
- Reviews (267)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
